'Why do children with cerebral palsy discontinue therapy with botulinum toxin A?'.
Michaela
M
Linder-Lucht
Janbernd
J
Kirschner
Jochen
J
Herrmann
Katrin
K
Geth
Rudolf
R
Korinthenberg
Steffen
S
Berweck
Florian
F
Heinen
Volker
V
Mall
D000293:Adolescent; D000906:Antibodies / Q000276:immunology; D019274:Botulinum Toxins, Type A / Q000276:immunology / Q000627:therapeutic use*; D002547:Cerebral Palsy / Q000188:drug therapy*; D002648:Child; D006801:Humans; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D012189:Retrospective Studies; D028761:Withholding Treatment
D000906:Antibodies; D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A